MedPath

Comparison the Effect of Intravenous Ketamine with Standard Treatment in Migraine Patients

Phase 3
Conditions
Migraine headache.
Migraine
Registration Number
IRCT20170224032753N2
Lead Sponsor
Bandare-abbas University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
46
Inclusion Criteria

Known migraine patients ,referring to emergency department of Shahid Mohammadi hospital in Bandarabbas
Age between 18 _ 70 years

Exclusion Criteria

history of cardiac disease
not complete the written consent
oxygen saturation level below 92 percent
systolic blood pressure below 90 or over 180 mmHg
heart rate below 50 or higher than 120 beat per minute
respiratory rate below 10 or higher than 30 per minute
consuming any analgesic 4 hour prior to study
pregnancy or lactation
liver cirrhosis
history of drug reaction with morphine or ketamine or other drugs used in the study
patients who are on dialysis
weight under 45 or more than 115 kg
presence of brain mass, chronic pulmonary disease , history of psychosis , or brain damage

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Headache intensity. Timepoint: Before treatment, 30 , 60 and 90 minutes after treatment. Method of measurement: Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath